These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6690744)

  • 1. Topical doxorubicin hydrochloride therapy for carcinoma in situ of the bladder: a followup.
    Jakse G; Hofstädter F; Marberger H
    J Urol; 1984 Jan; 131(1):41-2. PubMed ID: 6690744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravesical doxorubicin hydrochloride in the management of carcinoma in situ of the bladder.
    Jakse G; Hofstädter F
    Eur Urol; 1980; 6(2):103-6. PubMed ID: 7358059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravesical doxorubicin for prophylaxis in the management of recurrent superficial bladder carcinoma.
    Garnick MB; Schade D; Israel M; Maxwell B; Richie JP
    J Urol; 1984 Jan; 131(1):43-6. PubMed ID: 6690745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravesical chemotherapy for carcinoma in situ of the urinary bladder: 5 years later.
    Jakse G
    Eur Urol; 1984; 10(5):289-93. PubMed ID: 6440791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histological grading of carcinoma in situ of the bladder: its clinical significance in patients who underwent intravesical mitomycin C and doxorubicin sequential therapy.
    Sekine H; Fukui I; Yamada T; Yamada T; Kojima S; Ohshima H
    J Urol; 1996 Jan; 155(1):94-8; discussion 98-9. PubMed ID: 7490908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracavitary doxorubicin hydrochloride treatment for carcinoma in situ of the urinary bladder. A comparative study of two therapy regimens.
    Jakse G
    Eur Urol; 1981; 7(2):68-72. PubMed ID: 7461006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracavitary doxorubicin hydrochloride therapy for carcinoma in situ of the bladder.
    Jakse G; Hofstädter F; Marberger H
    J Urol; 1981 Feb; 125(2):185-90. PubMed ID: 7206051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravesical therapy with adriamycin in patients with superficial bladder tumors.
    Edsmyr F; Berlin T; Boman J; Duchek M; Esposti PL; Gustafsson H; Wijkström H; Collste LG
    Eur Urol; 1980; 6(3):132-6. PubMed ID: 7378141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical mitomycin C therapy for carcinoma in situ of the bladder: a followup.
    Stricker PD; Grant AB; Hosken BM; Taylor JS
    J Urol; 1990 Jan; 143(1):34-5; discussion 35-6. PubMed ID: 2104637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical mitomycin C therapy for carcinoma of the bladder.
    Stricker PD; Grant AB; Hosken BM; Taylor JS
    J Urol; 1987 Nov; 138(5):1164-6. PubMed ID: 3118056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravesical mitomycin C and doxorubicin sequential therapy for carcinoma in situ of the bladder: a longer followup result.
    Sekine H; Fukui I; Yamada T; Ohwada F; Yokokawa M; Ohshima H
    J Urol; 1994 Jan; 151(1):27-30. PubMed ID: 8254827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravesical instillation with adriamycin + tween 80 in patients with superficial bladder tumors: a preliminary report.
    Eksborg S; Edsmyr F; Näslund I
    Eur Urol; 1982; 8(4):213-5. PubMed ID: 7094962
    [No Abstract]   [Full Text] [Related]  

  • 13. Intravesical chemotherapy of carcinoma in situ in bladder cancer.
    Edsmyr F; Andersson L; Esposti PL
    Urology; 1984 Mar; 23(3 Suppl):37-9. PubMed ID: 6702054
    [No Abstract]   [Full Text] [Related]  

  • 14. ABH antigenicity of in situ carcinoma of the urinary bladder during intracavity treatment with doxorubicin hydrochloride.
    Jakse G; Hofstädter F
    Urol Res; 1981; 9(3):153-6. PubMed ID: 7257030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adriamycin instillations in carcinoma in situ of the bladder].
    Edsmyr F; Anderson L; Esposti PL
    Urologe A; 1983 Sep; 22 Suppl():337-41. PubMed ID: 6685384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of valrubicin for the treatment of Bacillus Calmette-Guerin refractory carcinoma in situ of the bladder. The Valrubicin Study Group.
    Steinberg G; Bahnson R; Brosman S; Middleton R; Wajsman Z; Wehle M
    J Urol; 2000 Mar; 163(3):761-7. PubMed ID: 10687972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravesical instillation of adriamycin in treatment of bladder cancer. A review.
    Pavone-Macaluso M; Battista Ingargiola G; Tripi M; Lamartina M
    Urology; 1984 Mar; 23(3 Suppl):40-7. PubMed ID: 6367194
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravesical adriamycin therapy in carcinoma in situ of the urinary bladder.
    Ek A; Hellsten S; Henrikson H; Idwall I; Lindholm CE; Lindholm K; Mikulowski P; Månsson W
    Scand J Urol Nephrol; 1984; 18(2):131-4. PubMed ID: 6463596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravesical chemotherapy in urinary bladder cancer.
    Edsmyr F; Anderson L; Esposti PL
    Cancer Chemother Pharmacol; 1983; 11 Suppl():S67-8. PubMed ID: 6640837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of mitomycin C and doxorubicin instillation on carcinoma in situ of the urinary bladder. A Finnish multicenter study.
    Jauhiainen K; Sotarauta M; Permi J; Alfthan O
    Eur Urol; 1986; 12(1):32-7. PubMed ID: 3081351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.